NO20052161L - Analysemetode for hjerte-karsykdom - Google Patents

Analysemetode for hjerte-karsykdom

Info

Publication number
NO20052161L
NO20052161L NO20052161A NO20052161A NO20052161L NO 20052161 L NO20052161 L NO 20052161L NO 20052161 A NO20052161 A NO 20052161A NO 20052161 A NO20052161 A NO 20052161A NO 20052161 L NO20052161 L NO 20052161L
Authority
NO
Norway
Prior art keywords
calprotectin
antibody
analysis
cardiovascular disease
body fluid
Prior art date
Application number
NO20052161A
Other languages
English (en)
Other versions
NO20052161D0 (no
Inventor
Erling Sundrehagen
Original Assignee
Axis Shield Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis Shield Asa filed Critical Axis Shield Asa
Publication of NO20052161D0 publication Critical patent/NO20052161D0/no
Publication of NO20052161L publication Critical patent/NO20052161L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Optical Head (AREA)
  • Gyroscopes (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Analysemetode for påvisning av potensial for hjerte-karsykdom (KVS) eller tilbøyelighet til hjerte-karsykdom (KVS) i et humant individ eller et ikke-humant dyreindivid, hvor metoden omfatter å bedømme konsentrasjonen av kalprotektin i en kalprotektinholdig prøve tatt fra det nevnte individ.
NO20052161A 2002-12-20 2005-05-03 Analysemetode for hjerte-karsykdom NO20052161L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0229747.1A GB0229747D0 (en) 2002-12-20 2002-12-20 Assay
PCT/GB2003/005607 WO2004057341A2 (en) 2002-12-20 2003-12-22 Cvd assay

Publications (2)

Publication Number Publication Date
NO20052161D0 NO20052161D0 (no) 2005-05-03
NO20052161L true NO20052161L (no) 2005-07-19

Family

ID=9950111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052161A NO20052161L (no) 2002-12-20 2005-05-03 Analysemetode for hjerte-karsykdom

Country Status (16)

Country Link
US (3) US10101325B2 (no)
EP (2) EP1573335B1 (no)
JP (2) JP4653492B2 (no)
CN (3) CN1729398B (no)
AT (2) ATE380345T1 (no)
AU (1) AU2003295142A1 (no)
CA (2) CA2729365C (no)
DE (2) DE60317931T2 (no)
DK (2) DK1739430T3 (no)
ES (2) ES2323475T3 (no)
GB (1) GB0229747D0 (no)
NO (1) NO20052161L (no)
PL (2) PL394295A1 (no)
PT (1) PT1573335E (no)
SI (1) SI1573335T1 (no)
WO (1) WO2004057341A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
US7659087B2 (en) 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
NZ553386A (en) 2004-07-23 2010-05-28 Aspenbio Pharma Inc Methods and devices for diagnosis of appendicitis
EP1862805A1 (en) * 2006-06-01 2007-12-05 University of Zürich The use of mrp 8/14 levels for discrimination of individuals at risk of acute coronary syndromes
EP3108949A1 (en) * 2009-03-02 2016-12-28 Dignity Health Diagnostic devices and methods of use
CN102421794B (zh) * 2009-05-07 2015-05-13 科雷托公司 用于纯化靶物多肽的方法
US9574977B2 (en) * 2013-02-26 2017-02-21 Innova Prep Liquid to liquid biological particle concentrator with disposable fluid path
EP2511704A1 (en) 2011-04-13 2012-10-17 Immundiagnostik AG Assay method for intrinsic acute kidney injury
NO20110895A1 (no) * 2011-06-21 2012-12-24 Magne Fagerhol Kompetitive S100A9 immunoanalyser
ES2402457B2 (es) * 2011-10-19 2014-01-20 Universidade De Vigo Procedimiento para el diagnóstico de derrame pleural maligno mediante la determinación de la concentración de calprotectina en líquido pleural.
US9122968B2 (en) 2012-04-03 2015-09-01 X-Card Holdings, Llc Information carrying card comprising a cross-linked polymer composition, and method of making the same
US9594999B2 (en) 2012-04-03 2017-03-14 X-Card Holdings, Llc Information carrying card comprising crosslinked polymer composition, and method of making the same
KR20150043566A (ko) * 2012-09-12 2015-04-22 버그 엘엘씨 심장독성 약제의 동정에 마커를 사용하는 용도
WO2014149926A1 (en) 2013-03-15 2014-09-25 X-Card Holdings, Llc Methods of making a core layer for an information carrying card, and resulting products
KR102457657B1 (ko) * 2017-02-07 2022-10-21 리프스톤 비.브이. 무균성 해리로 인한 임플란트 관련 임플란트 교정 위험을 진단하기 위한 바이오마커
EP3385712A1 (en) 2017-04-03 2018-10-10 Gentian AS Improved calprotectin assay
CN111094978B (zh) * 2017-05-09 2024-05-28 免疫诊断股份公司 免疫比浊法测定钙结合蛋白s100家族成员的方法
CN108196066A (zh) * 2018-01-22 2018-06-22 安徽伊普诺康生物技术股份有限公司 一种测定钙防卫蛋白的试剂盒及其制备使用方法
EP3762871A4 (en) 2018-03-07 2021-11-10 X-Card Holdings, LLC METAL CARD
EP4150337A1 (en) * 2020-05-13 2023-03-22 Nordic Bioscience A/S Calprotectin assay

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287202A (en) * 1978-05-26 1981-09-01 Horrobin David F Treatment and/or prophylaxis of spasms of coronary arteries
JPS55162059A (en) * 1979-06-05 1980-12-17 Mochida Pharmaceut Co Ltd Measuring method for antigen, antibody or their complex and measurement reagent kit
US4401765A (en) * 1981-09-01 1983-08-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
US4480042A (en) * 1981-10-28 1984-10-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
GB8318754D0 (en) * 1983-07-11 1983-08-10 Fagerhol M K F Human proteins anti-sera test kits
JPS60139621A (ja) 1983-12-27 1985-07-24 Grelan Pharmaceut Co Ltd 抗血栓剤
JPS625970A (ja) 1985-03-15 1987-01-12 Terumo Corp ピラジン誘導体およびこれを含有する血小板凝集抑制剤
EP0310361A3 (en) * 1987-09-30 1989-05-24 Beckman Instruments, Inc. Tridentate conjugate and method of use thereof
GB2218100A (en) 1988-03-02 1989-11-08 Erling Sundrehagen Conjugates for the detection and/or quantification of antigenic substances in body fluids
EP0414223B1 (en) * 1989-08-23 1996-06-26 Canon Kabushiki Kaisha Method for measuring an immunologically active material and apparatus suitable for practising said method
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
US5776348A (en) * 1995-02-07 1998-07-07 Massachusetts Institute Of Technology Mineral precipitation system and method for inhibiting mineral precipitate formation
JP4105768B2 (ja) * 1996-11-01 2008-06-25 マグネ・コー・ファージェルホール タンパク質の抽出方法
PT1493439E (pt) * 1997-04-02 2012-01-10 Brigham & Womens Hospital Meio de avaliação do perfil de risco de um indivíduo para uma doença aterosclerótica
GB9816088D0 (en) 1998-07-23 1998-09-23 Axis Biochemicals Asa System
WO2000011479A1 (en) * 1998-08-20 2000-03-02 Axis-Shield Asa Assay method for cardiovascular disease
EP2309275A1 (en) * 1999-07-05 2011-04-13 K.U.Leuven Research & Development Detection of Von-Willebrand factor (vwf) activity
CA2381926A1 (en) 1999-08-31 2001-03-08 Brigham And Women's Hospital, Inc. Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
FR2800636A1 (fr) * 1999-11-05 2001-05-11 Bio Merieux Particules composites, conjugues derives, leur procede de preparation et utilisations
US7011952B2 (en) * 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
US20030059461A1 (en) 2000-06-06 2003-03-27 Sibtech, Inc. Molecular delivery vehicle for delivery of selected compounds to targets
AU2001280210A1 (en) * 2000-08-29 2002-03-13 Kyowa Medex Co., Ltd. Highly reproducible agglutination immunoassay method and reagents
JP2002318233A (ja) * 2001-04-19 2002-10-31 Shino Test Corp 測定対象物質の比濁法測定試薬及び測定対象物質の比濁法測定方法
EP1666881B1 (en) * 2001-05-04 2010-02-17 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
GB0229747D0 (en) * 2002-12-20 2003-01-29 Axis Shield Asa Assay
FR2872579B1 (fr) * 2004-06-30 2006-11-24 Pasteur Institut Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha
WO2007106781A2 (en) * 2006-03-10 2007-09-20 University Of Rochester Ecg-based differentiation of lqt1 and lqt2 mutation

Also Published As

Publication number Publication date
EP1739430A2 (en) 2007-01-03
US10101325B2 (en) 2018-10-16
EP1739430B1 (en) 2009-04-01
JP2010019849A (ja) 2010-01-28
CA2729365C (en) 2018-09-18
CA2729365A1 (en) 2004-07-08
DK1573335T3 (da) 2008-04-14
CN1729398B (zh) 2012-04-04
ES2323475T3 (es) 2009-07-16
CN102608326A (zh) 2012-07-25
EP1573335B1 (en) 2007-12-05
CN1729398A (zh) 2006-02-01
DE60317931T2 (de) 2008-11-13
PL377476A1 (pl) 2006-02-06
WO2004057341A2 (en) 2004-07-08
JP5744385B2 (ja) 2015-07-08
PL394295A1 (pl) 2011-09-12
JP2006510895A (ja) 2006-03-30
CN101893635B (zh) 2014-04-09
WO2004057341A3 (en) 2004-10-21
ES2297250T3 (es) 2008-05-01
US20190049439A1 (en) 2019-02-14
CA2504876A1 (en) 2004-07-08
EP1573335A2 (en) 2005-09-14
JP4653492B2 (ja) 2011-03-16
ATE380345T1 (de) 2007-12-15
ATE427498T1 (de) 2009-04-15
EP1739430A3 (en) 2007-01-17
NO20052161D0 (no) 2005-05-03
PT1573335E (pt) 2007-12-21
AU2003295142A1 (en) 2004-07-14
US20110318847A1 (en) 2011-12-29
CN101893635A (zh) 2010-11-24
US20060134705A1 (en) 2006-06-22
PL216385B1 (pl) 2014-03-31
SI1573335T1 (sl) 2008-04-30
GB0229747D0 (en) 2003-01-29
DE60317931D1 (en) 2008-01-17
DK1739430T3 (da) 2009-07-13
DE60327007D1 (de) 2009-05-14

Similar Documents

Publication Publication Date Title
NO20052161D0 (no) Analysemetode for hjerte-karsykdom
Sener et al. Rapid real-time detection of procalcitonin using a microcontact imprinted surface plasmon resonance biosensor
WO2007011936A3 (en) Lateral flow assay and device using magnetic particles
NO20076656L (no) Forbedrede immunoassay metoder
Kim et al. Gold nanoparticle-based signal augmentation of quartz crystal microbalance immunosensor measuring C-reactive protein
Zhang et al. Sensitive detection of carcinoembryonic antigen in exhaled breath condensate using surface acoustic wave immunosensor
WO2010038974A3 (ko) 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트
DE60219207D1 (de) Diagnostisches testverfahren
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
EP2538218A8 (en) Biochemical markers for CVD risk assessment
WO2009117510A3 (en) Multi-wavelength analyses of sol-particle specific binding assays
WO2006047591A3 (en) Rapid microfluidic assay for analyte interactions
CN104330553B (zh) 一种无标记化学发光免疫传感器及其免疫分析方法
DE602007010032D1 (de) Immunoassay mit mehreren analyten
Salama et al. Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens
WO2005073405A3 (en) Catalytic polynucleotide and its use for determination of analytes
Koukouvinos et al. Rapid C-reactive protein determination in whole blood with a White Light Reflectance Spectroscopy label-free immunosensor for Point-of-Care applications
Pasinszki et al. Advances in celiac disease testing
SG157244A1 (en) Point of care test for the detection of exposure or immunity to dengue virus
WO2008063663A3 (en) Poly (ethylene glycol) anti-body detection assays and kits for performing thereof
Cennamo et al. Plasmon resonance biosensor for interleukin-1β point-of-care determination: A tool for early periodontitis diagnosis
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
Agafonova et al. Quartz crystal microbalance for the cardiac markers/antibodies binding kinetic measurements in the plasma samples
Gajos et al. Covalent and non-covalent in-flow biofunctionalization for capture assays on silicon chips: white light reflectance spectroscopy immunosensor combined with TOF-SIMS resolves immobilization stability and binding stoichiometry
Mikula et al. Electrochemical biosensor for the detection of glycated albumin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application